Antares Pharma Inc. (ATRS)
NASDAQ: ATRS
· Real-Time Price · USD
5.59
0.01 (0.18%)
At close: Apr 24, 2025, 3:47 PM
Antares Pharma Revenue Breakdown
| Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Licensing And Development Revenue Revenue | 4.19M | 3.79M | 3.68M | 7.17M | 4.98M | 5.7M | 4.32M | 2.69M | 1.75M | 3.16M | 1.21M | 2.24M | 915K | 1.13M | 2.55M | 1.78M |
| Licensing And Development Revenue Revenue Growth | +10.58% | +2.93% | -48.63% | +43.80% | -12.61% | +31.98% | +60.81% | +53.11% | -44.53% | +161.27% | -45.91% | +144.70% | -18.95% | -55.79% | +43.08% | n/a |
| Product Revenue | 32.1M | 36.56M | 11.44M | 27.9M | 29.14M | 33.13M | 28.95M | 24.66M | 27.1M | 28.5M | 24.69M | 20.62M | 18.3M | 14.23M | 11.6M | 11.1M |
| Product Revenue Growth | -12.19% | +219.55% | -59.00% | -4.23% | -12.05% | +14.43% | +17.36% | -8.98% | -4.91% | +15.43% | +19.72% | +12.68% | +28.61% | +22.70% | +4.52% | n/a |
| Royalty Revenue | 5.26M | 8.38M | n/a | 9.91M | 7.96M | 5.3M | 6.74M | 5.03M | 4.23M | 6.18M | 8.41M | 5.57M | 4.07M | 3.46M | 3.72M | 1.28M |
| Royalty Revenue Growth | -37.20% | n/a | n/a | +24.40% | +50.12% | -21.23% | +33.84% | +19.04% | -31.59% | -26.51% | +50.84% | +36.92% | +17.56% | -6.83% | +189.94% | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Sep 30, 2012 | Jun 30, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe Revenue | 1.46M | 2.96M | 310K | 970K | 1.45M | 1.98M | 632K | 586K | 609K | 19K | 566K | 788K | 2.09M | 1.11M | 1.83M | 1.79M | 1.42M | 2.04M | 750.47K | 1.11M | 1.16M | 2.29M | 1.22M | 1.05M | 1.57M | 2.42M | 1.31M | 828.65K | 6.76M | 7.1M | 5.82M | 1.74M | 1.09M | 1.32M | 1.05M | 604.27K | 933.64K | 787.37K | 1.49M |
| Europe Revenue Growth | -50.64% | +854.84% | -68.04% | -33.20% | -26.74% | +213.61% | +7.85% | -3.78% | +3105.26% | -96.64% | -28.17% | -62.30% | +87.78% | -39.18% | +1.95% | +26.50% | -30.54% | +172.22% | -32.52% | -3.74% | -49.48% | +88.20% | +16.04% | -33.18% | -35.13% | +84.47% | +58.06% | -87.75% | -4.73% | +21.90% | +233.73% | +60.81% | -17.53% | +25.58% | +73.39% | -35.28% | +18.58% | -47.14% | n/a |
| United States Revenue | 40.1M | 45.77M | 47.88M | 44.01M | 40.63M | 42.15M | 39.37M | 31.8M | 32.47M | 37.82M | 33.68M | 27.54M | 21.18M | 17.59M | 16.03M | 12.22M | 11.2M | 11.91M | 14.17M | 12.17M | 10.67M | 11.9M | 12.04M | 11.02M | 10.57M | n/a | n/a | 13.55M | 1.47M | 1.2M | 735.61K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -12.40% | -4.41% | +8.80% | +8.31% | -3.61% | +7.06% | +23.82% | -2.07% | -14.15% | +12.28% | +22.30% | +30.01% | +20.47% | +9.72% | +31.15% | +9.10% | -5.99% | -15.94% | +16.49% | +14.05% | -10.35% | -1.13% | +9.18% | +4.29% | n/a | n/a | n/a | +821.06% | +23.02% | +62.59% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 20.6M | 18.67M | 19.87M | 17.7M | 17.61M | 16.66M | 15.23M | 14.45M | 16.42M | 15.37M | 16.39M | 15.09M | 14.94M | 13.16M | 8.33M | 7.46M | 7.82M | 7.34M | 8.19M | 7.36M | 7.47M | 6.15M | 5.62M | 7.01M | 7.6M | 6.68M | 6.61M | 6.61M | 7.04M |
| Selling, General, and Administrative Revenue Growth | +10.34% | -6.05% | +12.26% | +0.55% | +5.70% | +9.37% | +5.42% | -12.02% | +6.87% | -6.22% | +8.60% | +1.02% | +13.52% | +57.99% | +11.58% | -4.52% | +6.49% | -10.33% | +11.22% | -1.44% | +21.34% | +9.45% | -19.84% | -7.74% | +13.87% | +1.00% | +0.09% | -6.14% | n/a |
| Research and Development Revenue | 5.01M | 3.89M | 3.92M | 4.05M | 2.64M | 2.32M | 2.4M | 2.42M | 2.98M | 2.88M | 2.86M | 2.49M | 2.39M | 1.75M | 3.61M | 3.65M | 3.32M | 3.61M | 3.29M | 3.16M | 3.09M | 5.57M | 5.96M | 3.95M | 5.65M | 5.64M | 5.14M | 4.57M | 4.38M |
| Research and Development Revenue Growth | +28.67% | -0.79% | -3.06% | +53.30% | +13.89% | -3.62% | -0.50% | -18.92% | +3.51% | +0.59% | +14.80% | +4.48% | +36.63% | -51.62% | -1.07% | +9.94% | -8.08% | +9.80% | +4.12% | +2.37% | -44.61% | -6.48% | +50.93% | -30.10% | +0.10% | +9.72% | +12.56% | +4.36% | n/a |